obesity drug news today glp-1 september 29 2025 Alarming rise in weight loss overdoses Periodic Graphics: The science of
Description
[DOI] [PMC free article] [PubMed] [Google Scholar] 37.He YL, Haynes W, Meyers CD, Amer A, Zhang Y, et al
The key finding was that plasma concentrations in patients taking 8 mg of retatrutide (approximately 182 nanomolar) exceeded the effective concentrations observed in the laboratory, suggesting these cardiac effects are clinically relevant at therapeutic doses
Novo Nordisk funded the study
However, hepatocytes do not express GLP-1R, making it difficult to appreciate its liver health advantages
Our bodies produce GLP-1 in response to certain foods, especially those high in protein and fiber
le Roux provides obesity clinical care in the Beyond BMI clinic and is a shareholder in the clinic
